David C. Hastings

2018 - Arbutus Biopharma Corp

In 2018, David C. Hastings earned a total compensation of $1.5M as Chief Financial Officer at Arbutus Biopharma Corp.

Compensation breakdown

Bonus$75,000
Non-Equity Incentive Plan$147,200
Option Awards$1,002,000
Salary$224,000
Other$4,667
Total$1,452,867

Hastings received $1M in option awards, accounting for 69% of the total pay in 2018.

Hastings also received $75K in bonus, $147.2K in non-equity incentive plan, $224K in salary and $4.7K in other compensation.

Rankings

In 2018, David C. Hastings' compensation ranked 7,316th out of 14,244 executives tracked by ExecPay. In other words, Hastings earned more than 48.6% of executives.

ClassificationRankingPercentile
All
7,316
out of 14,244
49th
Division
Manufacturing
2,831
out of 5,759
51st
Major group
Chemicals And Allied Products
1,063
out of 2,122
50th
Industry group
Drugs
898
out of 1,811
50th
Industry
Pharmaceutical Preparations
702
out of 1,385
49th
Source: SEC filing on April 23, 2019.

Hastings' colleagues

We found two more compensation records of executives who worked with David C. Hastings at Arbutus Biopharma Corp in 2018.

2018

Mark Murray

Arbutus Biopharma Corp

Chief Executive Officer

2018

Gaston Picchio

Arbutus Biopharma Corp

Chief Development Officer

News

In-depth

You may also like